Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias?

Greg J Elder, John-Paul Taylor, Greg J Elder, John-Paul Taylor

Abstract

Introduction: Two methods of non-invasive brain stimulation, transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), have demonstrable positive effects on cognition and can ameliorate neuropsychiatric symptoms such as depression. Less is known about the efficacy of these approaches in common neurodegenerative diseases. In this review, we evaluate the effects of TMS and tDCS upon cognitive and neuropsychiatric symptoms in the major dementias, including Alzheimer's disease (AD), vascular dementia (VaD), dementia with Lewy bodies (DLB), Parkinson's disease with dementia (PDD), and frontotemporal dementia (FTD), as well as the potential pre-dementia states of Mild Cognitive Impairment (MCI) and Parkinson's disease (PD).

Methods: PubMed (until 7 February 2014) and PsycINFO (from 1967 to January Week 3 2014) databases were searched in a semi-systematic manner in order to identify relevant treatment studies. A total of 762 studies were identified and 32 studies (18 in the dementias and 14 in PD populations) were included.

Results: No studies were identified in patients with PDD, FTD or VaD. Of the dementias, 13 studies were conducted in patients with AD, one in DLB, and four in MCI. A total of 16 of the 18 studies showed improvements in at least one cognitive or neuropsychiatric outcome measure. Cognitive or neuropsychiatric improvements were observed in 12 of the 14 studies conducted in patients with PD.

Conclusions: Both TMS and tDCS may have potential as interventions for the treatment of symptoms associated with dementia and PD. These results are promising; however, available data were limited, particularly within VaD, PDD and FTD, and major challenges exist in order to maximise the efficacy and clinical utility of both techniques. In particular, stimulation parameters vary considerably between studies and are likely to subsequently impact upon treatment efficacy.

Figures

Figure 1
Figure 1
Study search strategy and selection process.

References

    1. Wimo A, Winblad B, Jönsson L. The worldwide societal costs of dementia: estimates for 2009. Alzheimers Dement. 2010;6:98–103. doi: 10.1016/j.jalz.2010.01.010.
    1. Wancata J, Musalek M, Alexandrowicz R, Krautgartner M. Number of dementia sufferers in Europe between the years 2000 and 2050. Eur Psychiatry. 2003;18:306–313. doi: 10.1016/j.eurpsy.2003.03.003.
    1. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology. 2007;68:288–291. doi: 10.1212/01.wnl.0000252358.03285.9d.
    1. Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23:837–844. doi: 10.1002/mds.21956.
    1. Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O’Brien JT, Robbins TW, Wesnes K, Brooks DJ, Barker RA, Burn DJ. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD Study. Neurology. 2014;82:308–316. doi: 10.1212/WNL.0000000000000066.
    1. Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007;55:187–199. doi: 10.1016/j.neuron.2007.06.026.
    1. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120:2008–2039. doi: 10.1016/j.clinph.2009.08.016.
    1. Sandrini M, Umiltà C, Rusconi E. The use of transcranial magnetic stimulation in cognitive neuroscience: a new synthesis of methodological issues. Neurosci Biobehav Rev. 2011;35:516–536. doi: 10.1016/j.neubiorev.2010.06.005.
    1. Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. 2003;2:145–156. doi: 10.1016/S1474-4422(03)00321-1.
    1. Caparelli E, Backus W, Telang F, Wang G, Maloney T, Goldstein R, Henn F. Is 1 Hz rTMS always inhibitory in healthy individuals? Open Neuroimag J. 2012;6:69–74. doi: 10.2174/1874440001206010069.
    1. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005;45:201–206. doi: 10.1016/j.neuron.2004.12.033.
    1. Hoogendam JM, Ramakers GMJ, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 2010;3:95–118. doi: 10.1016/j.brs.2009.10.005.
    1. Luber B, Lisanby SH. Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS) Neuroimage. 2014;85:961–970. doi: 10.1016/j.neuroimage.2013.06.007.
    1. Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Hamdy A. Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson’s disease. Mov Disord. 2006;21:2201–2205. doi: 10.1002/mds.21089.
    1. Solé-Padullés C, Bartrés-Faz D, Junqué C, Clemente IC, Molinuevo JL, Bargalló N, Sánchez-Aldeguer J, Bosch B, Falcón C, Valls-Solé J. Repetitive transcranial magnetic stimulation effects on brain function and cognition among elders with memory dysfunction: a randomized sham-controlled study. Cereb Cortex. 2006;16:1487–1493. doi: 10.1093/cercor/bhj083.
    1. Hizli Sayar G, Ozten E, Tan O, Tarhan N. Transcranial magnetic stimulation for treating depression in elderly patients. Neuropsychiatr Dis Treat. 2013;9:501–504. doi: 10.2147/NDT.S44241.
    1. Schutter DJLG. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med. 2009;39:65–75. doi: 10.1017/S0033291708003462.
    1. O’Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208–1216. doi: 10.1016/j.biopsych.2007.01.018.
    1. Stagg CJ, Nitsche MA. Physiological basis of transcranial direct current stimulation. Neuroscientist. 2011;17:37–53. doi: 10.1177/1073858410386614.
    1. Brunoni AR, Nitsche MA, Bolognini N, Bikson M, Wagner T, Merabet L, Edwards DJ, Valero-Cabre A, Rotenberg A, Pascual-Leone A, Ferrucci R, Priori A, Boggio PS, Fregni F. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul. 2012;5:175–195. doi: 10.1016/j.brs.2011.03.002.
    1. Creutzfeldt OD, Fromm GH, Kapp H. Influence of transcortical d-c currents on cortical neuronal activity. Exp Neurol. 1962;5:436–452. doi: 10.1016/0014-4886(62)90056-0.
    1. Purpura DP, McMurtry JG. Intracellular activities and evoked potential changes during polarization of motor cortex. J Neurophysiol. 1965;28:166–185.
    1. Jacobson L, Koslowsky M, Lavidor M. tDCS polarity effects in motor and cognitive domains: a meta-analytical review. Exp Brain Res. 2012;216:1–10. doi: 10.1007/s00221-011-2891-9.
    1. Loo CK, Alonzo A, Martin D, Mitchell PB, Galvez V, Sachdev P. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry. 2012;200:52–59. doi: 10.1192/bjp.bp.111.097634.
    1. Antal A, Nitsche MA, Kruse W, Kincses TZ, Hoffmann K-P, Paulus W. Direct current stimulation over V5 enhances visuomotor coordination by improving motion perception in humans. J Cogn Neurosci. 2004;16:521–527. doi: 10.1162/089892904323057263.
    1. Zaehle T, Sandmann P, Thorne J, Jäncke L, Herrmann C. Transcranial direct current stimulation of the prefrontal cortex modulates working memory performance: combined behavioural and electrophysiological evidence. BMC Neurosci. 2011;12:2. doi: 10.1186/1471-2202-12-2.
    1. Reis J, Schambra HM, Cohen LG, Buch ER, Fritsch B, Zarahn E, Celnik PA, Krakauer JW. Noninvasive cortical stimulation enhances motor skill acquisition over multiple days through an effect on consolidation. Proc Natl Acad Sci U S A. 2009;106:1590–1595. doi: 10.1073/pnas.0805413106.
    1. Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer’s dementia. J Neurol. 2012;259:83–92. doi: 10.1007/s00415-011-6128-4.
    1. Cotelli M, Manenti R, Cappa SF, Geroldi C, Zanetti O, Rossini PM, Miniussi C. Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Arch Neurol. 2006;63:1602–1604. doi: 10.1001/archneur.63.11.1602.
    1. Cotelli M, Manenti R, Cappa SF, Zanetti O, Miniussi C. Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline. Eur J Neurol. 2008;15:1286–1292. doi: 10.1111/j.1468-1331.2008.02202.x.
    1. Cotelli M, Calabria M, Manenti R, Rosini S, Zanetti O, Cappa SF, Miniussi C. Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry. 2011;82:794–797. doi: 10.1136/jnnp.2009.197848.
    1. Bentwich J, Dobronevsky E, Aichenbaum S, Shorer R, Peretz R, Khaigrekht M, Marton RG, Rabey JM. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study. J Neural Transm. 2011;118:463–471. doi: 10.1007/s00702-010-0578-1.
    1. Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: a randomized, double-blind study. J Neural Transm. 2013;120:813–819. doi: 10.1007/s00702-012-0902-z.
    1. Turriziani P, Smirni D, Zappalà G, Mangano GR, Oliveri M, Cipolotti L. Enhancing memory performance with rTMS in healthy subjects and individuals with mild cognitive impairment: the role of the right dorsolateral prefrontal cortex. Front Hum Neurosci. 2012;6:8. doi: 10.3389/fnhum.2012.00062.
    1. Sedlackova S, Rektorova I, Fanfrdlova Z, Rektor I. Neurocognitive effects of repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia. J Psychophysiol. 2008;22:14–19. doi: 10.1027/0269-8803.22.1.14.
    1. Cotelli M, Calabria M, Manenti R, Rosini S, Maioli C, Zanetti O, Miniussi C. Brain stimulation improves associative memory in an individual with amnestic mild cognitive impairment. Neurocase. 2012;18:217–223. doi: 10.1080/13554794.2011.588176.
    1. Haffen E, Chopard G, Pretalli JB, Magnin E, Nicolier M, Monnin J, Galmiche J, Rumbach L, Pazart L, Sechter D, Vandel P. A case report of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease. Brain Stimul. 2012;5:264–266. doi: 10.1016/j.brs.2011.03.003.
    1. Boggio PS, Ferrucci R, Mameli F, Martins D, Martins O, Vergari M, Tadini L, Scarpini E, Fregni F, Priori A. Prolonged visual memory enhancement after direct current stimulation in Alzheimer’s disease. Brain Stimul. 2012;5:223–230. doi: 10.1016/j.brs.2011.06.006.
    1. Boggio PS, Khoury LP, Martins DC, Martins OE, de Macedo EC, Fregni F. Temporal cortex direct current stimulation enhances performance on a visual recognition memory task in Alzheimer disease. J Neurol Neurosurg Psychiatry. 2009;80:444–447. doi: 10.1136/jnnp.2007.141853.
    1. Cotelli M, Manentil R, Rosini S, Brambilla M, Zanetti O, Miniussi C. Brain stimulation in Alzheimer disease. Neuropsychol Trends. 2010;8:57–60.
    1. Ferrucci R, Mameli F, Guidi I, Mrakic-Sposta S, Vergari M, Marceglia S, Cogiamanian F, Barbieri S, Scarpini E, Priori A. Transcranial direct current stimulation improves recognition memory in Alzheimer disease. Neurology. 2008;71:493–498. doi: 10.1212/01.wnl.0000317060.43722.a3.
    1. Devi G, Voss HU, Levine D, Abrassart D, Heier L, Halper J, Martin L, Lowe S. Open-label, short-term, repetitive transcranial magnetic stimulation in patients with Alzheimer’s Disease with functional imaging correlates and literature review. Am J Alzheimers Dis Other Demen. 2014;29:248–255. doi: 10.1177/1533317513517047.
    1. Marras A, Pallanti S. Transcranial magnetic stimulation for the treatment of pharmacoresistant nondelusional auditory verbal hallucinations in dementia. Case Rep Psychiatry. 2013;2013:930304.
    1. Takahashi S, Mizukami K, Yasuno F, Asada T. Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy. Psychogeriatrics. 2009;9:56–61. doi: 10.1111/j.1479-8301.2009.00292.x.
    1. Suemoto CK, Apolinario D, Nakamura-Palacios EM, Lopes L, Paraizo Leite RE, Sales MC, Nitrini R, Brucki SM, Morillo LS, Magaldi RM, Fregni F. Effects of a non-focal plasticity protocol on apathy in moderate Alzheimer’s Disease: A randomized, double-blind, sham-controlled trial. Brain Stimul. 2014;7:308–313. doi: 10.1016/j.brs.2013.10.003.
    1. Benninger DH, Lomarev M, Lopez G, Wassermann EM, Li X, Considine E, Hallett M. Transcranial direct current stimulation for the treatment of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2010;81:1105–1111. doi: 10.1136/jnnp.2009.202556. A published erratum appears in J Neurol Neurosurg Psychiatry 2011, 82:354.
    1. Benninger DH, Berman BD, Houdayer E, Pal N, Luckenbaugh DA, Schneider L, Miranda S, Hallett M. Intermittent θ-burst transcranial magnetic stimulation for treatment of Parkinson disease. Neurology. 2011;76:601–609. doi: 10.1212/WNL.0b013e31820ce6bb.
    1. Boggio PS, Fregni F, Bermpohl F, Mansur CG, Rosa M, Rumi DO, Barbosa ER, Odebrecht Rosa M, Pascual-Leone A, Rigonatti SP, Marcolin MA, Araujo Silva MT. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson’s disease and concurrent depression. Mov Disord. 2005;20:1178–1184. doi: 10.1002/mds.20508.
    1. Boggio PS, Ferrucci R, Rigonatti SP, Covre P, Nitsche M, Pascual-Leone A, Fregni F. Effects of transcranial direct current stimulation on working memory in patients with Parkinson’s disease. J Neurol Sci. 2006;249:31–38. doi: 10.1016/j.jns.2006.05.062.
    1. Cardoso EF, Fregni F, Maia FM, Boggio PS, Luis Myczkowski ML, Coracini K, Lopes Vieira A, Melo LM, Sato JR, Marcolin MA, Rigonatti SP, Cruz AC Jr, Reis Barbosa E, Amaro E Jr. rTMS treatment for depression in Parkinson’s disease increases BOLD responses in the left prefrontal cortex. Int J Neuropsychopharmacol. 2008;11:173–183. doi: 10.1017/S1461145707007961.
    1. Dragasevic N, Potrebic A, Damjanovic A, Stefanova E, Kostic VS. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson’s disease: an open study. Mov Disord. 2002;17:528–532. doi: 10.1002/mds.10109.
    1. Epstein CM, Evatt ML, Funk A, Girard-Siqueira L, Lupei N, Slaughter L, Athar S, Green J, McDonald W, DeLong MR. An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson’s disease. Clin Neurophysiol. 2007;118:2189–2194. doi: 10.1016/j.clinph.2007.07.010.
    1. Fregni F, Santos CM, Myczkowski ML, Rigolino R, Gallucci-Neto J, Barbosa ER, Valente KD, Pascual-Leone A, Marcolin MA. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004;75:1171–1174. doi: 10.1136/jnnp.2003.027060.
    1. Fregni F, Ono CR, Santos CM, Bermpohl F, Buchpiguel C, Barbosa ER, Marcolin MA, Pascual-Leone A, Valente KD. Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. Neurology. 2006;66:1629–1637. doi: 10.1212/01.wnl.0000218194.12054.60.
    1. Furukawa T, Izumi S, Toyokura M, Masakado Y. Effects of low-frequency repetitive transcranial magnetic stimulation in Parkinson’s disease. Tokai J Exp Clin Med. 2009;34:63–71.
    1. Kormos TC. Efficacy of rTMS in the treatment of co-morbid anxiety in depressed patients with Parkinson’s disease. Mov Disord. 2007;22:1836. doi: 10.1002/mds.21613.
    1. Pal E, Nagy F, Aschermann Z, Balazs E, Kovacs N. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: a randomized, double-blind, placebo-controlled study. Mov Disord. 2010;25:2311–2317. doi: 10.1002/mds.23270.
    1. Sedlackova S, Rektorova I, Srovnalova H, Rektor I. Effect of high frequency repetitive transcranial magnetic stimulation on reaction time, clinical features and cognitive functions in patients with Parkinson’s disease. J Neural Transm. 2009;116:1093–1101. doi: 10.1007/s00702-009-0259-0.
    1. Srovnalova H, Marecek R, Kubikova R, Rektorova I. The role of the right dorsolateral prefrontal cortex in the Tower of London task performance: repetitive transcranial magnetic stimulation study in patients with Parkinson’s disease. Exp Brain Res. 2012;223:251–257. doi: 10.1007/s00221-012-3255-9.
    1. Chen R. Transcranial direct current stimulation as a treatment for Parkinson’s disease—interesting, but not ready for prime time. J Neurol Neurosurg Psychiatry. 2010;81:1061. doi: 10.1136/jnnp.2010.205112.
    1. Dlabac-de Lange JJ, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry. 2010;71:411–418. doi: 10.4088/JCP.08r04808yel.
    1. Ziemann U. TMS and drugs. Clin Neurophysiol. 2004;115:1717–1729. doi: 10.1016/j.clinph.2004.03.006.
    1. Liebetanz D, Nitsche MA, Tergau F, Paulus W. Pharmacological approach to the mechanisms of transcranial DC‐stimulation‐induced after‐effects of human motor cortex excitability. Brain. 2002;125:2238–2247. doi: 10.1093/brain/awf238.
    1. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293:596–608. doi: 10.1001/jama.293.5.596.
    1. Stokes MG, Chambers CD, Gould IC, English T, McNaught E, McDonald O, Mattingley JB. Distance-adjusted motor threshold for transcranial magnetic stimulation. Clin Neurophysiol. 2007;118:1617–1625. doi: 10.1016/j.clinph.2007.04.004.
    1. Wagner T, Eden U, Fregni F, Valero-Cabre A, Ramos-Estebanez C, Pronio-Stelluto V, Grodzinsky A, Zahn M, Pascual-Leone A. Transcranial magnetic stimulation and brain atrophy: a computer-based human brain model study. Exp Brain Res. 2008;186:539–550. doi: 10.1007/s00221-007-1258-8.
    1. Watson R, O’Brien JT, Barber R, Blamire AM. Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. Int Psychogeriatr. 2012;24:532–540. doi: 10.1017/S1041610211002171.
    1. Möller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, van der Flier WM. Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease. Neurobiol Aging. 2013;34:2014–2022. doi: 10.1016/j.neurobiolaging.2013.02.013.
    1. Nahas Z, Li X, Kozel FA, Mirzki D, Memon M, Miller K, Yamanaka K, Anderson B, Chae JH, Bohning DE, Mintzer J, George MS. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55–75 years of age: a pilot study. Depress Anxiety. 2004;19:249–256. doi: 10.1002/da.20015. A published erratum appears in Depress Anxiety 2010, 27:90.
    1. Bikson M, Rahman A, Datta A. Computational models of transcranial direct current stimulation. Clin EEG Neurosci. 2012;43:176–183. doi: 10.1177/1550059412445138.
    1. Datta A, Bansal V, Diaz J, Patel J, Reato D, Bikson M. Gyri-precise head model of transcranial direct current stimulation: improved spatial focality using a ring electrode versus conventional rectangular pad. Brain Stimul. 2009;2:201–207. doi: 10.1016/j.brs.2009.03.005.
    1. Bijsterbosch JD, Barker AT, Lee KH, Woodruff PW. Where does transcranial magnetic stimulation (TMS) stimulate? Modelling of induced field maps for some common cortical and cerebellar targets. Med Biol Eng Comput. 2012;50:671–681. doi: 10.1007/s11517-012-0922-8.
    1. McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A. et al.Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863–1872. doi: 10.1212/01.wnl.0000187889.17253.b1.
    1. Fields JA, Ferman TJ, Boeve BF, Smith GE. Neuropsychological assessment of patients with dementing illness. Nat Rev Neurol. 2011;7:677–687. doi: 10.1038/nrneurol.2011.173.
    1. Disner SG, Beevers CG, Haigh EA, Beck AT. Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci. 2011;12:467–477. doi: 10.1038/nrn3027.
    1. Wagner T, Valero-Cabre A, Pascual-Leone A. Noninvasive human brain stimulation. Annu Rev Biomed Eng. 2007;9:527–565. doi: 10.1146/annurev.bioeng.9.061206.133100.
    1. Zheng X, Alsop DC, Schlaug G. Effects of transcranial direct current stimulation (tDCS) on human regional cerebral blood flow. Neuroimage. 2011;58:26–33. doi: 10.1016/j.neuroimage.2011.06.018.
    1. Morgan HM, Davis NJ, Bracewell RM. Does transcranial direct current stimulation to prefrontal cortex affect mood and emotional memory retrieval in healthy individuals? PLoS One. 2014;9:e92162. doi: 10.1371/journal.pone.0092162.
    1. Robertson EM, Théoret H, Pascual-Leone A. Studies in cognition: the problems solved and created by transcranial magnetic stimulation. J Cogn Neurosci. 2003;15:948–960. doi: 10.1162/089892903770007344.
    1. Gandiga PC, Hummel FC, Cohen LG. Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation. Clin Neurophysiol. 2006;117:845–850. doi: 10.1016/j.clinph.2005.12.003.
    1. Davis NJ, Gold E, Pascual-Leone A, Bracewell RM. Challenges of proper placebo control for non-invasive brain stimulation in clinical and experimental applications. Eur J Neurosci. 2013;38:2973–2977.
    1. Brunoni AR, Kemp AH, Shiozawa P, Cordeiro Q, Valiengo LCL, Goulart AC, Coprerski B, Lotufo PA, Brunoni D, Perez ABA, Fregni F, Benseñor IM. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: Implications for the serotonergic system. Eur Neuropsychopharmacol. 2013;23:1530–1540. doi: 10.1016/j.euroneuro.2013.03.009.
    1. Wider C, Ross OA, Nishioka K, Heckman MG, Vilariño-Güell C, Jasinska-Myga B, Erketin-Taner N, Rademakers R, Graff-Radford NR, Mash DC, Papapetropoulos S, Duara R, Uchikado H, Wszolek ZK, Farrer MJ, Dickson DW. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer’s and Lewy body pathology. J Neurol Neurosurg Psychiatry. 2012;83:424–429. doi: 10.1136/jnnp-2011-301413.
    1. Williams-Gray CH, Hampshire A, Barker RA, Owen AM: Attentional control in Parkinson’s disease is dependent on COMT val158met genotype.Brain 2008, 131:397–408.
    1. Weiduschat N, Dubin MJ. Prefrontal cortical blood flow predicts response of depression to rTMS. J Affect Disord. 2013;150:699–702. doi: 10.1016/j.jad.2013.04.049.
    1. Bolognini N, Ro T. Transcranial magnetic stimulation: disrupting neural activity to alter and assess brain function. J Neuroscience. 2010;30:9647–9650. doi: 10.1523/JNEUROSCI.1990-10.2010.
    1. Pascual-Leone A, Walsh V, Rothwell J. Transcranial magnetic stimulation in cognitive neuroscience–virtual lesion, chronometry, and functional connectivity. Curr Opin Neurobiol. 2000;10:232–237. doi: 10.1016/S0959-4388(00)00081-7.
    1. Lancaster JL, Narayana S, Wenzel D, Luckemeyer J, Roby J, Fox P. Evaluation of an image-guided, robotically positioned transcranial magnetic stimulation system. Hum Brain Mapp. 2004;22:329–340. doi: 10.1002/hbm.20041.
    1. Nitsche MA, Cohen LG, Wassermann EM, Priori A, Lang N, Antal A, Paulus W, Hummel F, Boggio PS, Fregni F, Pascual-Leone A. Transcranial direct current stimulation: state of the art 2008. Brain Stimul. 2008;1:206–223. doi: 10.1016/j.brs.2008.06.004.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir